In this study, a dot-immunobinding assay (Dot-Iba) was standardized to meas
ure circulating antimycobacterial antibodies in the cerebrospinal fluid (CS
F) specimens for the rapid laboratory diagnosis of tuberculous meningitis (
TBM). Specific CSF-IgG antibody to Mycobacterium tuberculosis from a cultur
e proven patient with TBM was isolated and coupled with activated Cynogen b
romide-Sepharose 4B. Using an immunoabsorbent affinity chromatography, 14 k
Da antigen present in the culture filtrates of ill. tuberculosis was isolat
ed and this antigen was used in the Dot-Iba, to quantitate specific antimyc
obacterial antibodies in CSF specimens. The Dot-Iba gave positive results i
n all the 5 culture proven patients with TBM and gave no false positive res
ults in CSFs from patients with partially treated pyogenic meningitis. Dot-
Iba developed in our laboratory is a simple, rapid and specific method and
more importantly suited for the routine application in laboratories with li
mited resources.